Literature DB >> 378965

Transposition of ampicillin resistance to an enterotoxin plasmid in an Escherichia coli strain of human origin.

M M McConnell, G A Willshaw, H R Smith, S M Scotland, B Rowe.   

Abstract

We examined a strain of Escherichia coli, serotype O159.H34, of human origin which produced heat-stable and heat-labile enterotoxins, was resistant to ampicillin, and produced colicin. By conjugation and transformation experiments plasmids coding for enterotoxin production (Ent), enterotoxin production and ampicillin resistance (Ap-Ent), ampicillin resistance (Ap), and colicin production were isolated. Both the Ent and Ap-Ent plasmids were autotransferring and belonged to the F-incompatibility complex. However, the Apr Ent+ transconjugants showed differences in their levels of resistance and in their abilities to propagate F-specific phages and to transfer resistance. The results suggested there was transposition from the small Ap plasmid to the Ent plasmid. The Ap-Ent plasmids were larger than the enterotoxin factor and when treated with restriction endonuclease BamHI showed an additional fragment not present in the enterotoxin plasmid. The insertion of ampicillin resistance probably occurred at different sites on the enterotoxin plasmid, resulting in the observed variation in phenotype.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378965      PMCID: PMC216875          DOI: 10.1128/jb.139.2.346-355.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  36 in total

1.  Colicins.

Authors:  P FREDERICQ
Journal:  Annu Rev Microbiol       Date:  1957       Impact factor: 15.500

2.  EPISOMIC ELEMENT IN A STRAIN OF SALMONELLA TYPHOSA.

Authors:  S Falkow; L S Baron
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

3.  In vivo transfer of an Escherichia coli enterotoxin plasmid possessing genes for drug resistance.

Authors:  C Gyles; S Falkow; L Rollins
Journal:  Am J Vet Res       Date:  1978-09       Impact factor: 1.156

4.  Cholera-like diarrhea in Canada. Report of a case associated with enterotoxigenic Escherichia coli and a toxin-producing Aeromonas hydrophila.

Authors:  M Gurwith; C Bourque; E Cameron; G Forrest; M Green
Journal:  Arch Intern Med       Date:  1977-10

5.  Genetic map of the bacteriocinogenic plasmid CLO DF13 derived by insertion of the transposon Tn901.

Authors:  P M Andreoli; N Overbeeke; E Veltkamp; J D van Embden; H J Nijkamp
Journal:  Mol Gen Genet       Date:  1978-03-20

6.  Antimicrobial susceptibility of enterotoxigenic Escherichia coli.

Authors:  H L Dupont; H West; D G Evans; J Olarte; D J Evans
Journal:  J Antimicrob Chemother       Date:  1978-01       Impact factor: 5.790

7.  Method for the genetic labeling of cryptic plasmids.

Authors:  M So; F Heffron; S Falkow
Journal:  J Bacteriol       Date:  1978-03       Impact factor: 3.490

Review 8.  Transposable genetic elements and plasmid evolution.

Authors:  S N Cohen
Journal:  Nature       Date:  1976-10-28       Impact factor: 49.962

9.  Clonal distribution of resistance plasmid-carrying Salmonella typhimurium, mainly in the Middle East.

Authors:  E S Anderson; E J Threlfall; J M Carr; M M McConnell; H R Smith
Journal:  J Hyg (Lond)       Date:  1977-12

10.  Antimicrobial resistance and enterotoxin production among isolates of Escherichia coli in the Far East.

Authors:  P Echeverria; L Verhaert; C V Ulyangco; S Komalarini; M T Ho; F Orskov; I Orskov
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

View more
  12 in total

1.  The occurrence of plasmids carrying genes for both enterotoxin production and drug resistance in Escherichia coli of human origin.

Authors:  S M Scotland; R J Gross; T Cheasty; B Rowe
Journal:  J Hyg (Lond)       Date:  1979-12

Review 2.  Virulence versus resistance.

Authors:  K M Krasinski
Journal:  Bull N Y Acad Med       Date:  1987-04

3.  Mapping of a plasmid, coding for colonization, factor antigen I and heat-stable enterotoxin production, isolated from an enterotoxigenic strain of Escherichia coli.

Authors:  H R Smith; G A Willshaw; B Rowe
Journal:  J Bacteriol       Date:  1982-01       Impact factor: 3.490

4.  Molecular comparison of plasmids encoding heat-labile enterotoxin isolated from Escherichia coli strains of human origin.

Authors:  G A Willshaw; E A Barclay; H R Smith; M M McConnell; B Rowe
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

5.  Plasmids coding for colonization factor antigen I and heat-stable enterotoxin production isolated from enterotoxigenic Escherichia coli: comparison of their properties.

Authors:  M M McConnell; H R Smith; G A Willshaw; A M Field; B Rowe
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  Plasmids coding for heat-labile enterotoxin production isolated from Escherichia coli O78: comparison of properties.

Authors:  M M McConnell; H R Smith; G A Willshaw; S M Scotland; B Rowe
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

7.  Genetic and molecular studies of plasmids coding for colonization factor antigen I and heat-stable enterotoxin in several escherichia coli serotypes.

Authors:  G A Willshaw; H R Smith; M M McConnell; E A Barclay; J Krnjulac; B Rowe
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Antibiotic resistance in Enterotoxigenic and non-enterotoxigenic Escherichia coli.

Authors:  J M DeBoy; I K Wachsmuth; B R Davis
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

9.  Concurrent transfer and recombination between plasmids encoding for heat-stable enterotoxin and drug resistance in porcine enterotoxigenic Escherichia coli.

Authors:  A Franklin; R Möllby
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

10.  Effect of antibiotics on the prevalence of enterotoxigenic Escherichia coli in two populations in the Philippines.

Authors:  P Echeverria; P A Mejia; C Duangmani
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.